Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

NCT01835587

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Memorial Sloan-Kettering Cancer Center. New York, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
  • MD Anderson Cancer Center The University of Texas Houston, Texas, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Darbepoetin Alfa MDS Companion Protocol

NCT02175277

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Research Site Charleroi, Belgium
  • Research Site Leuven, Belgium
  • Research Site Liège, Belgium
  • Research Site Sint-Niklaas, Belgium
View Trial Details
Completed

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

NCT01868477

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +6 more
Locations
  • Novartis Investigative Site Oran, Algeria
  • Novartis Investigative Site Sidi Bel Abbes, Algeria
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site La Plata, Buenos Aires, Argentina
View all 30 locations
View Trial Details

Related conditions